+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glaucoma Surgery Devices Market by Surgery Type, Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 224 Pages
  • December 2021
  • Region: Global
  • Allied Market Research
  • ID: 5548392
Description Jump to:
The global glaucoma surgery devices market was valued at $818.46 million in 2020 and is projected to reach $6514.07 million by 2030 registering a CAGR of 24.60% from 2021 to 2030.



Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of eye called the optic nerve. It is the progressive loss of retinal ganglion cells and is associated with a characteristic optic neuropathy and visual field loss. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. The aim of glaucoma surgery is to lower eye pressure to prevent or reduce damage to the optic nerve with the use of glaucoma surgery devices. Glaucoma surgery devices such as stents, shunts, and micro implants are utilized for treatment of patients with mild-to-moderate glaucoma.

The factors that drive growth of the glaucoma surgery devices market include rise in prevalence of glaucoma, coupled with growth in geriatric population which are more prone to eye disease. In addition, increase in demand for minimal invasive glaucoma surgery (MIGS) procedures, and technological advancements in glaucoma surgery devices further boost growth of the glaucoma surgery devices market. However, reimbursement barriers regarding MIGS devices and risk of post-operative complications associated with glaucoma surgeries hamper growth of the market. Furthermore, lack of adequate skilled professionals to perform glaucoma surgeries, coupled with lack of awareness about eye care in low-income economies is also expected to limit growth of the market. In contrast, programs and initiatives to reduce burden of glaucoma across the globe and high growth potential in untapped emerging economies are some factors expected to offer lucrative growth opportunities for players in the glaucoma surgery devices market.

The global glaucoma surgery devices market is segmented on the basis of surgery type, product, end user, and region to provide a detailed assessment of the market. By surgery type, it is segmented into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. By product, the market is segmented into implants & stents, glaucoma drainage devices, and glaucoma laser devices. By end user, it is categorized into eye hospital & ophthalmology clinic, ambulatory surgical centers (ASCS), and outpatient surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the glaucoma surgery devices market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of glaucoma surgery devices used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

By Product

  • Implants & Stents
  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices

By End User

  • Eye Hospital & Ophthalmology Clinic
  • Ambulatory Surgical Centers (ASCS)
  • Outpatient Surgical Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • ABBVIE INC. (ALLERGAN)
  • ALCON INC
  • GLAUKOS CORPORATION
  • JOHNSON & JOHNSON (ABBOTT MEDICAL OPTICS)
  • ISTAR MEDICAL SA
  • LUMIBIRD MEDICAL (ELLEX MEDICAL LASERS LTD)
  • LUMENIS LTD
  • NEW WORLD MEDICAL, INC
  • SANTEN PHARMACEUTICAL CO. LTD
  • TOPCON CORPORATION

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in prevalence of glaucoma, coupled with growth in geriatric population
3.5.1.2. Increase in demand for minimally invasive glaucoma surgery (MIGS) procedures
3.5.1.3. Technological advancements in glaucoma surgery devices
3.5.2. Restraints
3.5.2.1. Reimbursement barriers regarding MIGS devices
3.5.2.2. Lack of adequate skilled professionals, coupled with lack of awareness about eye care in low-income economies
3.5.2.3. Risk of post-operative complications associated with glaucoma surgeries
3.5.3. Opportunities
3.5.3.1. Programs and initiatives to reduce burden of glaucoma across the globe
3.5.3.2. High growth potential in untapped emerging economies
3.5.4. Impact analysis
3.6. COVID-19 Impact analysis on the glaucoma surgery devices market
CHAPTER 4: GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Conventional glaucoma surgeries
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Minimally Invasive glaucoma surgeries
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Implants & stents
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Glaucoma drainage devices
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Glaucoma laser devices
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: GLAUCOMA SURGERY DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Eye hospitals & ophthalmology clinic
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ambulatory surgical centers (ASCs)
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Outpatient surgical centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: GLAUCOMA SURGERY DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. glaucoma surgery devices market, by surgery type
7.2.2.1.2. U.S. glaucoma surgery devices market, by product
7.2.2.1.3. U.S. glaucoma surgery devices market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada glaucoma surgery devices market, by surgery type
7.2.2.2.2. Canada glaucoma surgery devices market, by product
7.2.2.2.3. Canada glaucoma surgery devices market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico glaucoma surgery devices market, by surgery type
7.2.2.3.2. Mexico glaucoma surgery devices market, by product
7.2.2.3.3. Mexico glaucoma surgery devices market, by end user
7.2.3. North America market size and forecast, by surgery type
7.2.4. North America market size and forecast, by product
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany glaucoma surgery devices market, by surgery type
7.3.2.1.2. Germany glaucoma surgery devices market, by product
7.3.2.1.3. Germany glaucoma surgery devices market, by end user
7.3.2.2. France
7.3.2.2.1. France glaucoma surgery devices market, by surgery type
7.3.2.2.2. France glaucoma surgery devices market, by product
7.3.2.2.3. France glaucoma surgery devices market, by end user
7.3.2.3. UK
7.3.2.3.1. UK glaucoma surgery devices market, by surgery type
7.3.2.3.2. UK glaucoma surgery devices market, by product
7.3.2.3.3. UK glaucoma surgery devices market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy glaucoma surgery devices market, by surgery type
7.3.2.4.2. Italy glaucoma surgery devices market, by product
7.3.2.4.3. Italy glaucoma surgery devices market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain glaucoma surgery devices market, by surgery type
7.3.2.5.2. Spain glaucoma surgery devices market, by product
7.3.2.5.3. Spain glaucoma surgery devices market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe glaucoma surgery devices market, by surgery type
7.3.2.6.2. Rest of Europe glaucoma surgery devices market, by product
7.3.2.6.3. Rest of Europe glaucoma surgery devices market, by end user
7.3.3. Europe market size and forecast, by surgery type
7.3.4. Europe market size and forecast, by product
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan glaucoma surgery devices market, by surgery type
7.4.2.1.2. Japan glaucoma surgery devices market, by product
7.4.2.1.3. Japan glaucoma surgery devices market, by end user
7.4.2.2. China
7.4.2.2.1. China glaucoma surgery devices market, by surgery type
7.4.2.2.2. China glaucoma surgery devices market, by product
7.4.2.2.3. China glaucoma surgery devices market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia glaucoma surgery devices market, by surgery type
7.4.2.3.2. Australia glaucoma surgery devices market, by product
7.4.2.3.3. Australia glaucoma surgery devices market, by end user
7.4.2.4. India
7.4.2.4.1. India glaucoma surgery devices market, by surgery type
7.4.2.4.2. India glaucoma surgery devices market, by product
7.4.2.4.3. India glaucoma surgery devices market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea glaucoma surgery devices market, by Surgery type
7.4.2.5.2. South Korea glaucoma surgery devices market, by product
7.4.2.5.3. South Korea glaucoma surgery devices market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific glaucoma surgery devices market, by surgery type
7.4.2.6.2. Rest of Asia-Pacific glaucoma surgery devices market, by product
7.4.2.6.3. Rest of Asia-Pacific glaucoma surgery devices market, by end user
7.4.3. Asia-Pacific market size and forecast, by surgery type
7.4.4. Asia-Pacific market size and forecast, by product
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil glaucoma surgery devices market, by surgery type
7.5.2.1.2. Brazil glaucoma surgery devices market, by product
7.5.2.1.3. Brazil glaucoma surgery devices market, by end user
7.5.2.2. Turkey
7.5.2.2.1. Turkey glaucoma surgery devices market, by surgery type
7.5.2.2.2. Turkey glaucoma surgery devices market, by product
7.5.2.2.3. Turkey glaucoma surgery devices market, by end user
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia glaucoma surgery devices market, by surgery type
7.5.2.3.2. Saudi Arabia glaucoma surgery devices market, by product
7.5.2.3.3. Saudi Arabia glaucoma surgery devices market, by end user
7.5.2.4. South Africa
7.5.2.4.1. South Africa glaucoma surgery devices market, by surgery type
7.5.2.4.2. South Africa glaucoma surgery devices market, by product
7.5.2.4.3. South Africa glaucoma surgery devices market, by end user
7.5.2.5. Rest of LAMEA
7.5.2.5.1. Rest of LAMEA glaucoma surgery devices market, by surgery type
7.5.2.5.2. Rest of LAMEA glaucoma surgery devices market, by product
7.5.2.5.3. Rest of LAMEA glaucoma surgery devices market, by end user
7.5.3. LAMEA market size and forecast, by surgery type
7.5.4. LAMEA market size and forecast, by product
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC. (ALLERGAN)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. ALCON INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. GLAUKOS CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. JOHNSON & JOHNSON (ABBOTT MEDICAL OPTICS)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. ISTAR MEDICAL SA
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. LUMIBIRD MEDICAL (ELLEX MEDICAL LASERS LTD)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. LUMENIS LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. NEW WORLD MEDICAL, INC
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. SANTEN PHARMACEUTICAL CO. LTD.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. TOPCON CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 02. GLAUCOMA SURGERY DEVICES MARKET FOR CONVENTIONAL GLAUCOMA SURGERIES, BY REGION, 2020-2030($MILLION)
TABLE 03. GLAUCOMA SURGERY DEVICES MARKET FOR MINIMALLY INVASIVE GLAUCOMA SURGERIES, BY REGION, 2020-2030($MILLION)
TABLE 04. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 05. GLAUCOMA SURGERY DEVICES MARKET FOR IMPLANTS & STENTS, BY REGION, 2020-2030($MILLION)
TABLE 06. GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA DRAINAGE DEVICES, BY REGION, 2020-2030($MILLION)
TABLE 07. GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA LASER DEVICES, BY REGION, 2020-2030($MILLION)
TABLE 08. GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 09. GLAUCOMA SURGERY DEVICES MARKET FOR EYE HOSPITALS & OPHTHALMOLOGY CLINIC, BY REGION, 2020-2030($MILLION)
TABLE 10. GLAUCOMA SURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2020-2030($MILLION)
TABLE 11. GLAUCOMA SURGERY DEVICES MARKET FOR OUTPATIENT SURGICAL CENTERS, BY REGION, 2020-2030($MILLION)
TABLE 12. GLAUCOMA SURGERY DEVICES MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 14. U.S. GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 15. U.S. GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 16. U.S. GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 17. CANADA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 18. CANADA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 19. CANADA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 20. MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 21. MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 22. MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 23. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 24. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 25. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 26. EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 27. GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 28. GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 29. GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30. FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 31. FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 32. FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 33. UK GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 34. UK GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 35. UK GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 36. ITALY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 37. ITALY GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 38. ITALY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 39. SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 40. SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41. SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 42. REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 43. REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44. REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 45. EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 46. EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 47. EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 48. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 49. JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 50. JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 51. JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52. CHINA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 53. CHINA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 54. CHINA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 55. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 56. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 57. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 58. INDIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 59. INDIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 60. INDIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 61. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 62. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 63. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 64. REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 65. REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66. REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 67. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 68. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 69. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 70. LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 71. BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 72. BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 73. BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74. TURKEY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 75. TURKEY SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 76. TURKEY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 77. SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 78. SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 79. SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80. SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 81. SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 82. SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY END USER 2020-2030($MILLION)
TABLE 83. REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 84. REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 85. REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, END USER, 2020-2030($MILLION)
TABLE 86. LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
TABLE 87. LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 88. LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
TABLE 89. ABBVIE: COMPANY SNAPSHOT
TABLE 90. ABBVIE: OPERATING SEGMENTS
TABLE 91. ABBVIE: PRODUCT PORTFOLIO
TABLE 92. ALCON INC.: COMPANY SNAPSHOT
TABLE 93. ALCON INC.: OPERATING SEGMENTS
TABLE 94. ALCON INC.: PRODUCT PORTFOLIO
TABLE 95. ALCON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. GLAUKOS: COMPANY SNAPSHOT
TABLE 97. GLAUKOS: OPERATING SEGMENTS
TABLE 98. GLAUKOS: PRODUCT PORTFOLIO
TABLE 99. J&J: COMPANY SNAPSHOT
TABLE 100. J&J: OPERATING SEGMENTS
TABLE 101. J&J: PRODUCT TYPE PORTFOLIO
TABLE 102. ISTAR: COMPANY SNAPSHOT
TABLE 103. ISTAR: OPERATING SEGMENTS
TABLE 104. ISTAR: PRODUCT PORTFOLIO
TABLE 105. LUMIBIRD MEDICAL: COMPANY SNAPSHOT
TABLE 106. LUMIBIRD MEDICAL: OPERATING SEGMENTS
TABLE 107. LUMIBIRD MEDICAL: PRODUCT PORTFOLIO
TABLE 108. LUMENIS: COMPANY SNAPSHOT
TABLE 109. LUMENIS: OPERATING SEGMENTS
TABLE 110. LUMENIS: PRODUCT PORTFOLIO
TABLE 111. NEW WORLD MEDICAL: COMPANY SNAPSHOT
TABLE 112. NEW WORLD MEDICAL: OPERATING SEGMENTS
TABLE 113. NEW WORLD MEDICAL: PRODUCT PORTFOLIO
TABLE 114. SANTEN: COMPANY SNAPSHOT
TABLE 115. SANTEN: OPERATING SEGMENTS
TABLE 116. SANTEN: PRODUCT PORTFOLIO
TABLE 117. TOPCON CORPORATION: COMPANY SNAPSHOT
TABLE 118. TOPCON CORPORATION: OPERATING SEGMENTS
TABLE 119. TOPCON CORPORATION: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR CONVENTIONAL GLAUCOMA SURGERIES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR MINIMALLY INVASIVE GLAUCOMA SURGERIES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS GLAUCOMA SURGERY DEVICES MARKET FOR IMPLANTS & STENTS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA DRAINAGE DEVICES , BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA LASER DEVICES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR EYE HOSPITALS & OPHTHALMOLOGY CLINIC, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. ABBVIE: NET SALES, 2018-2020 ($MILLION)
FIGURE 22. ABBVIE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23. ALCON INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. ALCON INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25. ALCON INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26. GLAUKOS: NET SALES, 2018-2020 ($MILLION)
FIGURE 27. GLAUKOS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28. GLAUKOS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29. J&J: REVENUE, 2018-2020 ($MILLION)
FIGURE 30. J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. LUMIBIRD MEDICAL: NET SALES, 2018-2020, ($MILLION)
FIGURE 33. LUMIBIRD MEDICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. SANTEN: NET SALES, 2018-2020, ($MILLION)
FIGURE 35. TOPCON CORPORATION: NET SALES, 2018-2020, ($MILLION)
FIGURE 36. TOPCON CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. TOPCON CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)

Companies Mentioned

  • Abbvie Inc
  • (Allergan) Alcon Inc
  • Glaukos Corporation
  • Johnson & Johnson (Abbott Medical Optics)
  • Istar Medical Sa
  • Lumibird Medical (Ellex Medical Lasers Ltd) Lumenis Ltd
  • New World Medical, Inc.
  • Santen Pharmaceutical Co. Ltd
  • Topcon Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages224
PublishedDecember 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 722.22 million
Forecasted Market Value ( USD ) by 2030 $ 6514.07 million
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage Implant), Surgery Method, End-use, Region, and Segment Forecast 2024-2030 - Product Image

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage Implant), Surgery Method, End-use, Region, and Segment Forecast 2024-2030

  • Report
  • 120 Pages
  • Global
From
Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030 - Product Image

Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery Devices Market by Device, Indication, Surgery, End-User - Global Forecast 2025-2030 - Product Image

Minimally Invasive Glaucoma Surgery Devices Market by Device, Indication, Surgery, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Minimally Invasive Glaucoma Surgery Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 109 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.